Enhanced immunoprotective effects by Anti-IL17 antibody translates to improved skeletal parameters under estrogen deficiency compared to Anti-RANKL and Anti-TNFα antibodies
Journal of Bone and Mineral Research,  Clinical Article

Tyagi AM, et al. – Activated T cell has a key role in the interaction between bone and immune system. T cells produce pro–inflammatory cytokines including, RANKL, TNF–α and IL–17, all of which augment osteoclastogenesis. Based on the superior immunoprotective effects of anti–IL17 which appears to translate to a better skeletal preservation, the authors propose beginning clinical trials using a humanized antibody against IL–17 for treatment of post–menopausal osteoporosis.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore